Viewing Study NCT05217069


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-01-04 @ 12:44 AM
Study NCT ID: NCT05217069
Status: COMPLETED
Last Update Posted: 2025-04-16
First Post: 2019-01-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC
Sponsor: Ludwig-Maximilians - University of Munich
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module